| Name | Entrusted Hearts |
|---|---|
| Location | 7410 N 127th E Ave, Owasso, Oklahoma |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 377454 |
| Ownership Type | Voluntary Non Profit - Religious Affiliation |
| Service Area Zip Codes | 74012, 74019, 74021, 74035, 74037, 74044, 74047, 74053, 74055, 74070, 74102, 74106, 74107, 74112, 74128, 74131, 74145, 74146, 74361 |
| NPI Number | 1073571956 |
| Organization Name | BAPTIST VILLAGE RETIREMENT COMMUNITIES OF OKLAHOMA, INC |
| Doing Business As | ENTRUSTED HEARTS |
| Address | 7410 N 127th East Ave, Owasso, OK 74055 |
| Phone Number | 918-272-4694 |
News Archive
Pfenex Inc. announced today that it has granted Merck & Co., Inc., through an affiliate, an exclusive worldwide license to Pfenex Expression Technology(TM) Pseudomonas-based recombinant protein expression technology for the production of specific proteins to be used in the development of an undisclosed vaccine candidate.
The March of Dimes has committed another $2.6 million to support the work of six scientists for the next three years as they study the causes of preterm birth. The 2010 grants bring the six-year total of the March of Dimes Prematurity Research Initiative grant program to more than $15 million.
Corning Incorporated and BioCision, LLC today announced an agreement that will enable laboratories around the world to further standardize and simplify key steps in their cell culture workflow.
Olympus, a precision technology leader, designing and delivering innovative solutions in medical and surgical products, today announced the launch of the OER-Pro, the fastest technology in automated endoscope reprocessing and the only reprocessor on the market designed by an endoscope manufacturer.
› Verified 3 days ago
| NPI Number | 1134177223 |
| Organization Name | BAPTIST VILLAGE RETIREMENT COMMUNITIES OF OKLAHOMA, INC |
| Doing Business As | ENTRUSTED HEARTS PRIVATE SERVICES |
| Address | 7410 N 127th East Ave, Owasso, OK 74055 |
| Phone Number | 918-272-4694 |
News Archive
Pfenex Inc. announced today that it has granted Merck & Co., Inc., through an affiliate, an exclusive worldwide license to Pfenex Expression Technology(TM) Pseudomonas-based recombinant protein expression technology for the production of specific proteins to be used in the development of an undisclosed vaccine candidate.
The March of Dimes has committed another $2.6 million to support the work of six scientists for the next three years as they study the causes of preterm birth. The 2010 grants bring the six-year total of the March of Dimes Prematurity Research Initiative grant program to more than $15 million.
Corning Incorporated and BioCision, LLC today announced an agreement that will enable laboratories around the world to further standardize and simplify key steps in their cell culture workflow.
Olympus, a precision technology leader, designing and delivering innovative solutions in medical and surgical products, today announced the launch of the OER-Pro, the fastest technology in automated endoscope reprocessing and the only reprocessor on the market designed by an endoscope manufacturer.
› Verified 3 days ago
| Quality Rating: |
News Archive
Pfenex Inc. announced today that it has granted Merck & Co., Inc., through an affiliate, an exclusive worldwide license to Pfenex Expression Technology(TM) Pseudomonas-based recombinant protein expression technology for the production of specific proteins to be used in the development of an undisclosed vaccine candidate.
The March of Dimes has committed another $2.6 million to support the work of six scientists for the next three years as they study the causes of preterm birth. The 2010 grants bring the six-year total of the March of Dimes Prematurity Research Initiative grant program to more than $15 million.
Corning Incorporated and BioCision, LLC today announced an agreement that will enable laboratories around the world to further standardize and simplify key steps in their cell culture workflow.
Olympus, a precision technology leader, designing and delivering innovative solutions in medical and surgical products, today announced the launch of the OER-Pro, the fastest technology in automated endoscope reprocessing and the only reprocessor on the market designed by an endoscope manufacturer.
› Verified 3 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 98.7 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 98.7 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 96.2 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 82.2 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 84.2 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 95.8 | 96.4 |
News Archive
Pfenex Inc. announced today that it has granted Merck & Co., Inc., through an affiliate, an exclusive worldwide license to Pfenex Expression Technology(TM) Pseudomonas-based recombinant protein expression technology for the production of specific proteins to be used in the development of an undisclosed vaccine candidate.
The March of Dimes has committed another $2.6 million to support the work of six scientists for the next three years as they study the causes of preterm birth. The 2010 grants bring the six-year total of the March of Dimes Prematurity Research Initiative grant program to more than $15 million.
Corning Incorporated and BioCision, LLC today announced an agreement that will enable laboratories around the world to further standardize and simplify key steps in their cell culture workflow.
Olympus, a precision technology leader, designing and delivering innovative solutions in medical and surgical products, today announced the launch of the OER-Pro, the fastest technology in automated endoscope reprocessing and the only reprocessor on the market designed by an endoscope manufacturer.
› Verified 3 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 70.7 | 79.6 |
| How often patients got better at getting in and out of bed | 100 | 81.1 |
| How often patients got better at bathing | 88.4 | 82.3 |
| How often patients’ breathing improved | 74.7 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 45 | 75 |
| How often home health patients had to be admitted to the hospital | 13.7 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 10.6 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 97.4 | 94 |
News Archive
Pfenex Inc. announced today that it has granted Merck & Co., Inc., through an affiliate, an exclusive worldwide license to Pfenex Expression Technology(TM) Pseudomonas-based recombinant protein expression technology for the production of specific proteins to be used in the development of an undisclosed vaccine candidate.
The March of Dimes has committed another $2.6 million to support the work of six scientists for the next three years as they study the causes of preterm birth. The 2010 grants bring the six-year total of the March of Dimes Prematurity Research Initiative grant program to more than $15 million.
Corning Incorporated and BioCision, LLC today announced an agreement that will enable laboratories around the world to further standardize and simplify key steps in their cell culture workflow.
Olympus, a precision technology leader, designing and delivering innovative solutions in medical and surgical products, today announced the launch of the OER-Pro, the fastest technology in automated endoscope reprocessing and the only reprocessor on the market designed by an endoscope manufacturer.
› Verified 3 days ago
News Archive
Pfenex Inc. announced today that it has granted Merck & Co., Inc., through an affiliate, an exclusive worldwide license to Pfenex Expression Technology(TM) Pseudomonas-based recombinant protein expression technology for the production of specific proteins to be used in the development of an undisclosed vaccine candidate.
The March of Dimes has committed another $2.6 million to support the work of six scientists for the next three years as they study the causes of preterm birth. The 2010 grants bring the six-year total of the March of Dimes Prematurity Research Initiative grant program to more than $15 million.
Corning Incorporated and BioCision, LLC today announced an agreement that will enable laboratories around the world to further standardize and simplify key steps in their cell culture workflow.
Olympus, a precision technology leader, designing and delivering innovative solutions in medical and surgical products, today announced the launch of the OER-Pro, the fastest technology in automated endoscope reprocessing and the only reprocessor on the market designed by an endoscope manufacturer.
› Verified 3 days ago
Accentra Home Health - Northeastern Location: 8551 North 125th East Avenue, Suite 300, Owasso, Oklahoma 74055 Ratings: Phone: (918) 272-5388 |